Skip to main content
NCBI home page
British Journal of Experimental Pathology logoLink to British Journal of Experimental Pathology
. 1986 Jun;67(3):313–319.

Alpha 2 macroglobulin of the rat, an acute phase protein, mitigates the early course of endotoxin shock.

H van Vugt, J van Gool, L de Ridder
PMCID: PMC2013026  PMID: 2424486

Abstract

Normal rats and rats with high levels of alpha 2 macrofetoprotein (alpha M FP), an acute phase globulin induced by pretreatment with BaSO4 i.p., were injected with sublethal doses of endotoxin. One hour survival was better in the group with high levels of alpha M FP (36%) than in controls (9%). All rats receiving purified alpha M FP i.p. survived. Recovery of mean arterial blood pressure, expressed as the surface area under the curve, was significantly better in the groups with high alpha M FP levels. Leakage of i.v. administered human albumin was the same in control and BaSO4 pretreated rats. BaSO4 induces peritonitis which could explain the albumin leakage. Experiments were repeated therefore in rats pretreated with adrenaline which also initiates the production of alpha M FP. In this group, I h survival after endotoxin administration was 100% and albumin leakage was significantly less than in rats receiving either endotoxin only or BaSO4-pretreatment. In early endotoxin shock prostaglandins, including PGE2 a potent vasodilatator, are released into the circulation. From previous data it is known that alpha M FP prevents the vasodilatation and increased vascular permeability caused by PGE2. Rats with high levels of alpha M FP had a smaller fall in diastolic blood pressure after PGE2 administration than did controls with normal alpha M FP levels. The effects of alpha M FP on the haemodynamic events in early endotoxin shock could well be due to inhibition of PGE2 activity.

Full text

PDF
313

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aasen A. O., Frolich W., Saugstad O. D., Amundsen E. Plasma kallikrein activity and prekallikrein levels during endotoxin shock in dogs. Eur Surg Res. 1978;10(1):50–62. doi: 10.1159/000127992. [DOI] [PubMed] [Google Scholar]
  2. Bhatnagar R., Schade U., Rietschel E. T., Decker K. Involvement of prostaglandin E and adenosine 3', 5'-monophosphate in lipopolysaccharide-stimulated collagenase release by rat Kupffer cells. Eur J Biochem. 1982 Jun 15;125(1):125–130. doi: 10.1111/j.1432-1033.1982.tb06659.x. [DOI] [PubMed] [Google Scholar]
  3. Birmelin M., Decker K. Synthesis of prostanoids and cyclic nucleotides by phagocytosing rat Kupffer cells. Eur J Biochem. 1984 Jul 16;142(2):219–225. doi: 10.1111/j.1432-1033.1984.tb08274.x. [DOI] [PubMed] [Google Scholar]
  4. Camara D. S., Caruana J. A., Jr, Schwartz K. A., Montes M., Nolan J. P. D-Galactosamine liver injury: absorption of endotoxin and protective effect of small bowel and colon resection in rabbits. Proc Soc Exp Biol Med. 1983 Feb;172(2):255–259. doi: 10.3181/00379727-172-41555. [DOI] [PubMed] [Google Scholar]
  5. Cook J. A., Wise W. C., Callihan C. S. Resistance of essential fatty acid-deficient rats to endotoxic shock. Circ Shock. 1979;6(4):333–342. [PubMed] [Google Scholar]
  6. Cook J. A., Wise W. C., Halushka P. V. Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency. J Clin Invest. 1980 Jan;65(1):227–230. doi: 10.1172/JCI109655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fletcher J. R., Ramwell P. W. Modification, by aspirin and indomethacin, of the haemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog. Br J Pharmacol. 1977 Oct;61(2):175–181. doi: 10.1111/j.1476-5381.1977.tb08402.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Freudenberg M. A., Bøg-Hansen T. C., Back U., Galanos C. Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats. Infect Immun. 1980 May;28(2):373–380. doi: 10.1128/iai.28.2.373-380.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Freudenberg M. A., Freudenberg N., Galanos C. Time course of cellular distribution of endotoxin in liver, lungs and kidneys of rats. Br J Exp Pathol. 1982 Feb;63(1):56–65. [PMC free article] [PubMed] [Google Scholar]
  10. Liehr H., Grün M., Seelig H. P., Seelig R., Reutter W., Heine W. D. On the pathogenesis of galactosamine hepatitis. Indications of extrahepatocellular mechanisms responsible for liver cell death. Virchows Arch B Cell Pathol. 1978 Feb 14;26(4):331–344. doi: 10.1007/BF02889560. [DOI] [PubMed] [Google Scholar]
  11. Ufkes J. G., Zeegers A., Boers W., van Gool J. Inhibitory effects of BaSO4 on experimentally induced inflammation in the rat mediated by alpha M-foetoprotein. Arch Int Pharmacodyn Ther. 1983 Apr;262(2):287–298. [PubMed] [Google Scholar]
  12. Wise W. C., Cook J. A., Halushka P. V., Knapp D. R. Protective effects of thromboxane synthetase inhibitors in rats in endotoxic shock. Circ Res. 1980 Jun;46(6):854–859. doi: 10.1161/01.res.46.6.854. [DOI] [PubMed] [Google Scholar]
  13. van Gool J., Boers W., de Nie I. Inhibitory effects of rat alpha2 macroferoprotein (alphaMFP), an acute phase globulin, on galactosamine hepatitis. Exp Mol Pathol. 1978 Oct;29(2):228–240. doi: 10.1016/0014-4800(78)90041-2. [DOI] [PubMed] [Google Scholar]

Articles from British journal of experimental pathology are provided here courtesy of Wiley

RESOURCES